Day Three Labs

Company Overview

Snapshot

Founded in November 2021 by Josh Rubin and Rafi Cohen, Day Three Labs operates with 1–10 employees. The company has raised $6.08 million across 3 funding rounds from 4 investors. In January 2022, Day Three Labs acquired revolutionary pharmaceutical-grade cannabinoid infusion technology.

Business overview

Day Three Labs is a cannabinoid CPG ingredient manufacturer specializing in the development and commercialization of novel cannabis product solutions. The company's core product, Unlokt, is an ingestible cannabinoid remedy that uses a natural protein to deliver cannabis directly into circulation, bypassing first-pass metabolization and preserving terpenes and cannabinoids. Day Three Labs serves the Health Tech & Life Sciences sector, focusing on medical cannabis, drug development, and novel ingredients within pharmaceuticals.

Strategic signal

In February 2023, Day Three Labs announced a breakthrough in edible cannabis technology, unlocking new potential for the market. This development signals a significant advancement in cannabinoid delivery, potentially enhancing product efficacy and consumer experience, and positioning the company as an innovator in the pharmaceutical-grade cannabis space.

Company Intelligence Q&A

What is the primary focus of Day Three Labs?

Day Three Labs specializes in developing and commercializing novel cannabis product solutions as a cannabinoid CPG ingredient manufacturer.

What is Unlokt?

Unlokt is an ingestible cannabinoid remedy developed by Day Three Labs that utilizes a natural protein to deliver cannabis directly into circulation, preserving its active compounds and bypassing first-pass metabolization.

When did Day Three Labs acquire its cannabinoid infusion technology?

In January 2022, Day Three Labs acquired revolutionary pharmaceutical-grade cannabinoid infusion technology.

What was a key development announced by Day Three Labs in early 2023?

In February 2023, Day Three Labs announced a breakthrough that unlocks the potential of edible cannabis, indicating advancements in their infusion technology.

Which investors participated in Day Three Labs' December 2021 funding round?

In December 2021, Day Three Labs received funding from Key Investment Partners and Phyto Partners.